I first took beta blockers two years ago, when I was asked to give a eulogy. Terrible at public speaking on a good day, let alone at a funeral, my first instinct was to refuse to do it. I had made a ...

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...

An unlikely byproduct of the Oscars red-carpet coverage last Sunday? The mention of beta blockers by actor Rachel Sennott, who told a host that her pre-event routine is to “take that beta blocker, ...

Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association's 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained ...

Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows. In ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

Without question, there is a fair deal of negative stigma surrounding traditional psychopharmaceutical treatments for problems such as anxiety, depression, and panic. While these medications of ...

A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction ...

MADRID -- Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.